Request a demo specialized to your need.
Turn CTMS events into auditable journal entries with secure automation.
Map clinical events to finance with a shared data layer
A durable CTMS–ERP integration begins with a shared semantic layer that translates operational reality into finance-ready data. Start by normalizing study-building blocks—countries, sites, visits, procedures, milestones—so they are uniquely identified, versioned, and linked to contract terms and cost categories. For each potential financial trigger (e.g., site activation, first patient in, completed visit, database lock, closeout tasks), define the evidence source of truth in your operational systems and the rule that determines when the trigger is “finance-eligible.” For example, a per-visit payment might require a completed visit in EDC plus no open critical queries for that visit; a start-up fee might require regulatory greenlight, contract execution, and essential-doc pack completeness in eTMF. Consistency here eliminates ambiguous invoices and builds trust with sites and vendors. Establish master data that finance depends on but operations often overlook: site banking formats and tax pack status by country, rate cards and modifiers (screen-fail, early term), currency preferences, and approval thresholds. Capture these as first-class records with owners, version history, and effective dates so the integration never relies on tribal knowledge. Name and classify cost categories narrowly enough to drive accurate mapping, but stably enough to survive protocol amendments. Maintain a living data dictionary that explains how CTMS objects map to the general ledger’s chart of accounts, subledgers, and dimensions (e.g., study, country, site, vendor).
This is the contract between teams—and auditors will ask to see it. Design data lineage from operational evidence through transformation to journal entries. Document where calculations occur, how rounding and FX policies are applied, and which inputs are authoritative when systems disagree. For computerized systems used in clinical trials, regulators expect validated, secure, and traceable records; see FDA principles at FDA computerized systems. Frame integration requirements with ICH’s modern quality-by-design mindset to keep focus on what is critical to quality; see ICH E8(R1) at ICH E8(R1) and ICH E6(R3) at ICH E6(R3).
Automate journal entries with validated, auditable flows
Once the shared data layer is defined, automate journal entry creation with a control framework that auditors can trust. Treat each finance event as the output of a rules engine that evaluates eligibility, calculates amounts, and attaches evidence. For example: when a site activation milestone is met (all prerequisites true), raise a payable candidate and generate the corresponding accrual or expense entry in the ERP subledger with references to the CTMS evidence. For visit-based line items, use event-driven logic: a completed visit in EDC/CTMS creates a pre-validated payable with links to visit IDs, subject IDs, and contract rates. Implement three-way matching—contract term, operational evidence, and invoice line—so approvals focus on exceptions rather than routine items. Engineer layered validation. Syntactic checks verify required fields and formats; semantic checks confirm business rules (e.g., the contracted rate exists for the site and effective date); conformance checks apply FX policy and tax rules based on country pack logic.
Publish your FX policy—spot vs. rolling average, booking window, which party bears conversion costs—and codify it so the integration produces consistent results. For cross-border payments, define banking data requirements (IBAN, SWIFT/BIC, CLABE) and pre-disbursement checks; see European Payments Council SEPA background at EPC SEPA. For participant reimbursements that often feed financial entries, align with ethics guidance to avoid undue influence; see FDA perspective at FDA subject payment guidance. Keep transport concerns separate from business logic. Use queues for resilience, idempotent processing for updates and retries, and correlation IDs so acknowledgments and error payloads can be reconciled quickly. Every automated action should write an immutable audit record with who/what/when/why. Where you model controls and configurations as machine-readable artifacts, consider open formats for documenting controls; NIST’s OSCAL illustrates principles for portable, testable control documentation at NIST OSCAL.
Govern, measure, and evolve integration for inspections
Sustained integration quality is a governance problem as much as a technical one. Establish a cross-functional change board that owns mapping tables, validation packs, and policy configurations (FX, tax, evidence rules). Require impact assessments, versioned change logs, and rollback plans for any update that changes financial outcomes. Operate dashboards that show end-to-end health—message throughput, exception aging, auto-match rate, on-time disbursement ratio, FX variance within tolerance, and audit trail completeness—so leaders can intervene early. Tie metric targets to critical-to-quality factors to reinforce ICH E6(R3)’s proportional oversight; see the final guideline at ICH E6(R3). Inspection readiness depends on proving design and operation over time. Maintain a living “from plan to proof” package that links SOPs, validation summaries, configuration exports, mapping dictionaries, sample transaction trails, and training records. Run periodic mock audits that trace a sample entry from operational trigger through journal posting and payment, confirming attribution, approvals, and evidence. For U.S. tax and disclosure contexts that sometimes intersect with financial records, maintain awareness of investigator financial disclosure expectations so records can be reconciled when needed; see FDA’s overview at FDA financial disclosure. Finally, build a feedback loop: reconcile estimates to actuals, analyze variance by site and cost type, and feed lessons into your mapping and rules. Done well, CTMS-to-ERP integration turns finance from a reactive function into a transparent, real-time partner to clinical operations—without sacrificing compliance.
Subscribe to our Newsletter